Skip to main content

Stonnington Group, LLC

SEC CIK
0001325261
Latest filing
Apr 14, 2023

BMRN holding history

Biomarin Pharmaceutical Inc in every 13F filed by Stonnington Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BMRN overviewAll 13F holders of BMRNFull Q1 2023 holdings

Shares (Q1 2023)
9,100
Value
$894.9K
% of portfolio
0.2%
Quarters held
6
Since Q3 2021
Holdings of BMRN by Stonnington Group, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20239,100$894.9K0.2%+1,500+19.7%AddedHolders
Q4 20227,600$846.6K0.2%−300−3.8%ReducedHolders
Q3 20227,900$698.0K0.2%+3,700+88.1%AddedHolders
Q2 20224,200$371.0K0.1%+1,200+40.0%AddedHolders
Q1 20223,000$250.0K0.1%+3,000NewHolders
Q4 20210$00.0%−5,800−100.0%Sold outHolders
Q3 20215,800$451.0K0.1%+5,800NewHolders